| | 1009119-65-6 Basic information More.. |
| Product Name: | Daclatasvir Dihydrochloride | | Synonyms: | BMS 790052;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;Daclatasvir`Daclatasvir dihydrochloride;Dclatasvir dihydrochloride;Daclatasvir Digydrochloride;Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2);Daclatasvir API;Dackatasvir dihydrochloride | | CAS: | 1009119-65-6 | | MF: | C40H51ClN8O6 | | MW: | 775.35 | | EINECS: | 816-965-3 | | Mol File: | 1009119-65-6.mol |  |
Use
Daclatasvir Dihydrochloride is the dihydrochloride salt form of daclatasvir, an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin).
- Daclatasvir
-
- US $0.00 / Kg/Bag
- 2024-04-22
- CAS:1009119-65-6
- Min. Order: 2Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
|
|
1009119-65-6
Recommend Suppliers |
|